Phase IB and pharmacological study of the novel taxane BMS-184476 in combination with doxorubicin.

Sessa, C; Perotti, A; Salvatorelli, E; Minotti, G; Viganò, L; Lladò, A; Capri, G; Locatelli, A; Colombini, S; Peccatori, F; Voi, M; Marsoni, S; Gianni, L

Sessa, C; Perotti, A; Salvatorelli, E; Minotti, G; Viganò, L; Lladò, A; Capri, G; Locatelli, A; Colombini, S; Peccatori, F; Voi, M; Marsoni, S; Gianni, L.

Affiliation

Sessa C; Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland.

Eur J Cancer ; 40(4): 563-70, 2004 Mar.

Article in En | MEDLINE | ID: mdl-14962724

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/pharmacokinetics; Neoplasms/drug therapy; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Doxorubicin/administration & dosage; Doxorubicin/adverse effects; Doxorubicin/pharmacokinetics; Heart/drug effects; Humans; Maximum Tolerated Dose; Middle Aged; Myocardium; Taxoids/administration & dosage; Taxoids/adverse effects; Taxoids/pharmacokinetics

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Neoplasms Limits: Aged / Humans / Middle aged Language: En Journal: Eur J Cancer Year: 2004 Type: Article Affiliation country: Switzerland

Search on Google

XML

PubMed Links